Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate [NA]

View source ↗

Summary

A clinical trial sponsored by NIDDK is investigating the effects of nicotinamide riboside on ketosis, fat oxidation, and metabolic rate in adults with overweigh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Overweight, Obesity | NA | Status: RECRUITING